NASDAQConsumer StaplesPackaged FoodsSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for NCRA yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Prudent capital allocation avoiding excessive dilution | A supporting condition in NOCERA INC's published investment case. The stated target is No further dilutive equity sales beyond current agreements in next 4 quarters. | Intact | New dilutive equity sales announced within next 4 quarters | Qualitative condition This condition has no defined numerical measure. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 7–Nov 5 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, high-risk situation rather than an established compounder. The thesis is in a watch state: recent performance is weak, management execution is volatile, and the evidence is not strong enough to call the business trajectory settled.
The valuation evidence is mixed: NCRA appears cheap versus peers, while the model also indicates a 39% premium to peers and an expectations gap of -0.79. Confidence in the valuation model is low, so the market's assumptions are hard to pin down; the snapshot labels pricing as justified and fragility as low.
Near term, fundamentals remain pressured because the company is loss-making and recent financial performance sits well below its industry cohort. Management has made progress on a strategic partnership and acquisitions, but cash from operations remains negative, and the company recently faced financial-reporting and listing-compliance events. Over the multi-year view, execution on these priorities matters, while the sector tailwind offers support but does not resolve the business's operating weaknesses.
A weaker jobs trend could deepen recession concerns and weigh on cyclical businesses, while continued earnings strength and higher guidance from KHC, GIS, and SJM could sustain sector momentum. Misses or lower guidance from those peers would weaken that support. NCRA's own ability to improve financial performance and manage acquisitions and capital needs is also central, though the evidence on this is limited.
Over the next 1 to 3 years, the long-term thesis remains fragile in operating terms despite a supportive sector backdrop and some strategic progress. The key questions are whether execution improves and whether sector strength persists. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Management is working to meet Nasdaq listing requirements. |
| Under Pressure |
| Fails to meet Nasdaq listing requirements leading to delisting |
Nasdaq equity requirement failed (Apr 2026 notice) Nasdaq notified company of non-compliance with minimum stockholders' equity rules in April 2026. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue stabilizes or improves | A primary condition in NOCERA INC's published investment case. The stated target is Revenue decline less than -5% YoY or positive growth next year. | Intact | Revenue decline exceeds -14% YoY next year | Revenue growth: -46.13% FY2026-Q2; GAAP. Published target: Revenue decline less than -5% YoY or positive growth next year. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Aug 5, 2026-46.129985 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Successful execution of strategic partnership with Phoenix MGMT | Nocera has formed a strategic partnership with Phoenix MGMT to support growth. | Improving | No meaningful progress or milestones achieved from partnership within 4 quarters | 3 milestones vs 4Q target Signed E-PRO distribution deal, Digital Innovations venture, and AI consulting agreement; new CFO appointed. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.